|
|
Article: U.S. Patent covering protein formulations of engineered zinc fingers granted.
- Article from:
- Health & Medicine Week
- Article date:
- December 27, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 DEC 27 - (NewsRx.com & NewsRx.net) -- Sangamo BioSciences, Inc. (SGMO) has been granted a United States patent entitled "Regulation of Endogenous Gene Expression in Cells Using Zinc Finger Proteins."
The patent covers the activation or repression of any endogenous gene, in any cell, in any organism using engineered zinc finger DNA-binding proteins (ZFPs) and broadens Sangamo's patent coverage of the uses of engineered ZFPs to include delivery of ZFP Therapeutics as recombinant proteins. Similar patents have been granted or allowed in the European Union and Australia and counterpart applications are pending worldwide.
Zinc finger DNA-binding ...